Expertise in
17
conditions

Marcel P. Arnold

Bern, BE, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
17
conditions
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Marcel Arnold practices in Bern, Switzerland. Mr. Arnold is highly rated in 17 conditions, according to our data. His top areas of expertise are Stroke, Thrombophlebitis, Mesenteric Venous Thrombosis, Thrombectomy, and Craniectomy.

His clinical research consists of co-authoring 355 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bern, BE, Switzerland
Other Locations
Basel, BS, Switzerland
Cantonal Hospital St. Gallen, St. Gallen All In Switzerland, Sankt Gallen, SG, Switzerland
Schwerzenbach, ZH, Switzerland
Zurich, ZH, Switzerland
Munchenstein, BL, Switzerland
Lugano, TI, Switzerland
St Gallen Cantonal Hospital, St Gallen
Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Enrollment Status: Unknown
Publish Date: November 11, 2021
The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis
The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis
Enrollment Status: Completed
Publish Date: October 12, 2018
Intervention Type: Other
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)
Enrollment Status: Terminated
Publish Date: February 14, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

355 Total Publications

Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.
Journal: European stroke journal
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arnold's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile